Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The year in review: coronary interventions.
Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns RM, Capodanno D, Byrne RA, Wijns W, Onuma Y, Serruys PW. Gao C, et al. Among authors: sharif f. EuroIntervention. 2020 Apr 17;15(17):1534-1547. doi: 10.4244/EIJ-D-19-01124. EuroIntervention. 2020. PMID: 32091399 Free article. Review. No abstract available.
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications.
Ewen S, Lauder L, Azizi M, Kandzari DE, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher TF. Ewen S, et al. Among authors: sharif f. EuroIntervention. 2018 Aug 3;14(5):e598-e602. doi: 10.4244/EIJY18M07_1. EuroIntervention. 2018. PMID: 29970353 Free article. Clinical Trial. No abstract available.
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications.
Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo MD, Sharif F, Wijns W, Tsioufis C, Mahfoud F. Lauder L, et al. Among authors: sharif f. EuroIntervention. 2018 Aug 3;14(5):e603-e606. doi: 10.4244/EIJY18M07_2. EuroIntervention. 2018. PMID: 29970354 Free article. Clinical Trial. No abstract available.
Renal artery denervation: a lot done and more to do.
Sharif F. Sharif F. EuroIntervention. 2018 Dec 20;14(12):e1252-e1254. doi: 10.4244/EIJV14I12A225. EuroIntervention. 2018. PMID: 30566080 Free article. No abstract available.
Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update.
Kawashima H, Ono M, Kogame N, Takahashi K, Chang CC, Hara H, Gao C, Wang R, Tomaniak M, Modolo R, Wykrzykowska JJ, De Winter RJ, Sharif F, Serruys PW, Onuma Y. Kawashima H, et al. Among authors: sharif f. Expert Opin Drug Deliv. 2020 Jul;17(7):931-945. doi: 10.1080/17425247.2020.1764932. Epub 2020 May 27. Expert Opin Drug Deliv. 2020. PMID: 32456554 Review.
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.
Hara H, van Klaveren D, Takahashi K, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Wang R, Gao C, Niethammer M, Fontos G, Angioi M, Ribeiro VG, Barbato E, Leandro S, Hamm C, Valgimigli M, Windecker S, Jüni P, Steg PG, Verbeeck J, Tijssen JGP, Sharif F, Onuma Y, Serruys PW; GLOBAL LEADERS Trial Investigators. Hara H, et al. Among authors: sharif f. Circ Cardiovasc Qual Outcomes. 2020 Aug;13(8):e006660. doi: 10.1161/CIRCOUTCOMES.120.006660. Epub 2020 Jul 30. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32762446
Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging.
Ono M, Kawashima H, Hara H, Gao C, Wang R, Kogame N, Takahashi K, Chichareon P, Modolo R, Tomaniak M, Wykrzykowska JJ, Piek JJ, Mori I, Courtney BK, Wijns W, Sharif F, Bourantas C, Onuma Y, Serruys PW. Ono M, et al. Among authors: sharif f. Front Cardiovasc Med. 2020 Jul 31;7:119. doi: 10.3389/fcvm.2020.00119. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32850981 Free PMC article. Review.
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial.
Hara H, Gao C, Kogame N, Ono M, Kawashima H, Wang R, Morel MA, O'Leary N, Sharif F, Möllmann H, Reiber JHC, Sabaté M, Zaman A, Wijns W, Onuma Y, Serruys PW. Hara H, et al. Among authors: sharif f. EuroIntervention. 2020 Dec 18;16(12):e997-e1004. doi: 10.4244/EIJ-D-20-00772. EuroIntervention. 2020. PMID: 32928717 Free article. Clinical Trial.
468 results